On February 8, the PMDA held the “PMDA-ATC COVID-19 related In Vitro diagnostics (IVDs) Webinar for the Medical Device Authority (MDA), the Ministry of Health Malaysia.”
The webinar reviewed COVID-19 related IVDs. The PMDA shared information on the Japanese regulatory system and PMDA’s experiences with 66 MDA staff members engaged in medical devices regulation including their premarket control.
The PMDA continues to promote collaboration with MDA through training seminars and other activities.
See attached program.
Back
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
International Activities
Safety Information
Advanced Efforts
-
Information for approved products in Japan
Safety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulatory science
-
Regulations and services of PMDA
Information for approved products in Japan
Procedures in Japan
Advanced efforts
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Reviews and Related Services
Regulatory Procedures
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety
Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC COVID-19 related IVDs Webinar for MDA, Malaysia
Events and Symposia